Copperwynd Financial, LLC Pfizer Inc Transaction History

Copperwynd Financial, LLC

$330 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $68,808 - $80,630	2,724 Added 14.18%	21,935 $613,000
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $133,411 - $153,198	5,153 Added 36.66%	19,211 $533,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $7,969 - $10,351	-305 Reduced 2.12%	14,058 $404,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $28,335 - $33,121	-883 Reduced 5.79%	14,363 $476,000
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $34,928 - $40,410	967 Added 6.77%	15,246 $559,000
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $8,035 - $10,461	204 Added 1.45%	14,279 $582,000
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $9,560 - $12,480	-229 Reduced 1.6%	14,075 $721,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $51,986 - $63,462	-1,188 Reduced 7.67%	14,304 $626,000
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $2.05 Million - $2.43 Million	-44,002 Reduced 73.96%	15,492 $812,000
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $2.89 Million - $3.59 Million	-63,275 Reduced 51.54%	59,494 $3.08 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $4.52 Million - $6.7 Million	109,434 Added 820.65%	122,769 $7.25 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $24,649 - $31,663	628 Added 4.94%	13,335 $574,000
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $30,487 - $34,537	-849 Reduced 6.26%	12,707 $498,000
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $2,813 - $3,172	84 Added 0.62%	13,556 $491,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $22,090 - $28,089	660 Added 5.15%	13,472 $496,000
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $8,286 - $9,722	-261 Reduced 2.0%	12,812 $470,000
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $27,077 - $32,849	-899 Reduced 6.43%	13,073 $427,000
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $57,357 - $81,951	2,122 Added 17.91%	13,972 $456,000
Q4 2019 Jan 23, 2020	SELL	$32.92 - $37.36 $50,466 - $57,272	-1,533 Reduced 11.45%	11,850 $464,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $72,550 - $94,076	2,233 Added 20.03%	13,383 $494,000
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $1,331 - $1,494	-36 Reduced 0.32%	11,150 $483,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $35,175 - $38,645	-938 Reduced 7.74%	11,186 $475,000
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $82,133 - $93,641	-2,135 Reduced 14.97%	12,124 $529,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $491,507 - $596,168	14,259 New	14,259 $628,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Account